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A B S T R A C T
Background
A prosthesis can be divided into several components: the prosthetic socket; the prosthetic ankle-foot mechanism; and for higher levels
of amputation, the prosthetic knee. This review focuses on the prosthetic ankle-foot mechanism, which forms an important part of the
prosthesis in terms of mobility. A correct prosthetic prescription can be derived by matching the functional abilities of the individual
with a lower limb amputation with the technical and functional aspects of the various prosthetic ankle-foot mechanisms. However,
there seems to be no clear clinical consensus on the precise prescription criteria for the various prosthetic ankle-foot mechanisms in
relation to the functional abilities of individuals with a lower limb amputation.
Objectives
To obtain information about aspects of prosthetic ankle-foot mechanisms and daily functioning of individuals with a lower limb
prosthesis, for appropriate prosthetic prescription criteria.
Search methods
We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (April 2006), the Cochrane Central Register of
Controlled Trials (The Cochrane Library 2006, Issue 2), MEDLINE (1966 to April 2006), EMBASE (1983 to April 2006), CINAHL
(1982 to April 2006), AMED (Allied and Complimentary Medicine) (1985 to April 2006), and reference lists of articles. No language
restrictions were applied.
Selection criteria
All randomised controlled trials and quasi-randomised controlled trials comparing different ankle foot mechanisms for lower limb
amputation in adults. No language restrictions were applied.
Data collection and analysis
Two review authors independently identified potential articles from the literature search. Methodological quality was assessed using a
checklist comprising 13 criteria. The reviewers extracted data using pre-defined extraction forms.
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Main results
Twenty-six trials were included, with a total of 245 participants. The numbers of participants in the included trials ranged from three
to sixteen. The methodological quality was moderate. Only one study was of high quality. All included studies used cross-over designs
allowing sufficient control for confounding.
In individuals with a transtibial amputation, there seems to be a small tendency towards a greater stride length when walking with the
Flex-foot in comparison to the SACH (solid-ankle cushioned heel) foot. When walking speed was increased, the energy cost was lower.
In high activity individuals with a transfemoral amputation, there is limited evidence for the superiority of the Flex foot during level
walking compared with the SACH foot in respect of energy cost and gait efficiency.
Authors’ conclusions
There is insufficient evidence from high quality comparative studies for the overall superiority of any individual type of prosthetic
ankle-foot mechanism, although there is a small trend towards the Flex-foot in comparison with the SACH foot for greater stride
length and lower energy cost in individuals with a transtibial amputation, and improved gait efficiency and lower energy cost in high
activity individuals with a transfemoral amputation. In prescribing prosthetic-ankle foot mechanisms for individuals with a lower limb
amputation, practitioners should take into account availability, patient functional needs, the type of knee mechanism to be prescribed
and the inter-relationship with ankle-foot mechanisms, and cost.
P L A I N L A N G U A G E S U M M A R Y
There is not enough evidence to establish precise criteria for the prescription of prosthetic ankle-foot mechanisms in individuals
with a lower limb amputation.
There are many different prosthetic ankle-foot mechanisms available. When prescribing a prosthesis, the goal is to help individuals
with a lower limb amputation return to their place in society, participating in activities that are important to them. This means finding
a prosthesis that is appropriate for their level of activity, ability and weight.
In high activity individuals with a transfemoral amputation, there is limited evidence for the superiority of the Flex foot during level
walking compared with the solid-ankle cushioned heel (SACH) foot in respect of energy cost and, gait efficiency. This benefit has
only been confirmed in individuals with a transtibial amputation during decline and incline walking and increased walking speeds.
In prescribing prosthetic-ankle foot mechanisms for individuals with a lower limb amputation, practitioners should take into account
availability, patient functional needs, the type of kneemechanism tobe prescribed and the inter-relationshipwith ankle-footmechanisms,
and cost.
B A C K G R O U N D
Prosthetic prescription for individuals with a lower limb amputa-
tion is primarily based on empirical knowledge. Many options are
available for different prosthetic components; however, prescrip-
tion criteria are based mainly on subjective experiences of physi-
cians, therapists, and prosthetists (Goh 1984; Menard 1992). On
the other hand, third-party payers frequently require justification
for purchasing costly prostheses (Menard 1992). Also, clarity for
the customer is required since quality of care is becoming more
important.
In the ideal situation, prosthetic prescription is based on adjust-
ing the mechanical characteristics of a prosthesis to the functional
needs of the prosthesis user (Cortes 1997), yet no clinical guide-
lines seem to be available for this use. The development of scientif-
ically based clinical guidelines is a way of making health care more
consistent and efficient and diminishes the gap between what clin-
icians do and what scientific evidence supports. A systematic lit-
erature review is the first step in clinical guideline development. It
may also highlight knowledge gaps in the existing evidence (Woolf
1999).
To our knowledge, no scientifically based guidelines for lower-
limb prosthetic prescription exist. Also, no consensus seems to
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exist among different professionals with regard to the criteria for
selecting prosthetic components related to the functional abili-
ties and needs of patients. In this perspective, we have decided to
develop clinical guidelines for lower limb prosthetic prescription
in order to obtain transparency and consensus among clinicians,
manufacturers and insurance companies. The first step is to ob-
tain explicit knowledge from the literature. For this purpose, the
types of studies we are interested in are studies addressing motor
performance and/or daily functioning of individuals with a lower
limb amputation. These studies focus on subjective findings, en-
ergy expenditure, or gait parameters. In view of clinical guideline
development these studies are considered most relevant for pros-
thetic prescription. Hence, this review will be restricted to these
clinically oriented studies.
O B J E C T I V E S
The aim of this review was to obtain information about aspects
of prosthetic ankle-foot mechanisms and daily functioning of
adult individuals with a lower limb amputation. This information
should provide an objective starting point for further development
of consensus-based criteria for prosthetic prescription.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials and quasi-randomised controlled
trials comparing different prosthetic devices for lower limb ampu-
tation in adults.
Types of participants
All adult (18-80 years of age) transfemoral, through-knee, and
transtibial individuals with dysvascular, traumatic, congenital, or
oncologic amputations. Because amputation levels other than
these require individual prescription, these amputation levels (e.g.
hip disarticulation or toe amputations) are not included in this
review. There were no race or gender restrictions, or restrictions
on setting.
Types of interventions
Any trials which compare the ankle-foot mechanisms currently
in use such as SACH-feet, Flex-feet, Seattle-feet, Single-Axis feet.
Trials investigating amputation techniques or early prosthetic fit-
ting (i.e. use of a temporary prosthesis prior to the permanent
prosthesis) were excluded.
Types of outcome measures
Motor performance and activities of daily living (ADL) function-
ing are important for prosthetic prescription, therefore data were
sought for the following outcome measures:
1. Subjective findings: preference, satisfaction, Borg-scale, ease of
walking, outcome of questionnaires (Prosthesis Evaluation Ques-
tionnaire, Prosthetic Profile of the Amputee, Locomotor Capabil-
ities Index, Sickness Impact Profile, Nottingham Health Profile,
Reintegration to Normal Living)
2. Energy expenditure: oxygen consumption, heart rate
3. Stride characteristics: walking speed, walking distance, stride
length, step length, stride time, cadence, stance phase duration,
swing phase duration
4. Kinetic parameters: ground reaction force
5. Kinematic parameters: joint motion (ankle dorsiflexion, ankle
plantar flexion, knee flexion and extension, hip flexion and exten-
sion)
Search methods for identification of studies
We searched the Cochrane Bone, Joint andMuscle Trauma Group
Specialised Register of trials (April 2006), the Cochrane Central
Register of Controlled Trials (The Cochrane Library 2006, Issue
2), MEDLINE (1966 to April 2006), EMBASE (1983 to April
2006), CINAHL (1982 to April 2006), AMED (Allied and Com-
plimentary Medicine) (1985 to April 2006), and reference lists of
articles. No language restrictions were applied.
The current search strategy for MEDLINE (OVID Web 2003 to
April 2006) and the previous MEDLINE search strategy (Silver-
platter 1966 to April 2003) are shown in Appendix 1. The subject
specific part of these strategies were combined with a modification
of the optimal trial search strategy (McDonald 2002). TheMED-
LINE strategy was modified for use in EMBASE (OVID Web;
Appendix 2),The Cochrane Library (Wiley InterScience; Appendix
3), CINAHL (OVIDWeb; Appendix 4) andAMED(OVIDWeb;
Appendix 5).
Data collection and analysis
Selection of studies
Two review authors independently assessed the abstracts of all
studies identified by the initial search and excluded non-relevant
studies. Full text articles were obtained for any studies with unclear
methodology or when abstracts were not available. Disagreement
on inclusion was resolved by consulting a third reviewer. Full text
articles were obtained for any studies which passed the inclusion
criteria as described above.
Study quality
Methodological quality was assessed using a checklist comprising
13 criteria. This checklist was based on two existing criteria lists
for quality assessment (Tulder 1997; Verhagen 1998), which were
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originally developed to evaluate randomised controlled trials. Each
criterion was scored according to three levels: no = ’0’, yes = ’1’ or
not applicable = ’NA’. The selected studies were analysed by two
review authors and differences resolved by discussion.
Selection of patients
A1: Adequacy of description of inclusion and exclusion criteria.
This criterion tested whether the patient sample was sufficiently
defined using selection criteria. At least three of the following de-
scriptives were required: age, level of amputation, reason for am-
putation, activity level of the participant, time since onset, stump
condition, comorbidity, and sex.
A2: Homogeneity. The homogeneity of the study sample was as-
sessed, in relation to activity level, age and reason for amputation.
For the purpose of this review, the activity level of the investigated
participants should be similar. In case the activity level of the indi-
viduals with a lower limb amputation was not described, at least an
indication of the level of amputation, the reason for amputation,
and the age of the participants was required to assess the activity
level of the individuals with a lower limb amputation. If the study
sample was a heterogeneous population, an adequate stratification
of the outcome parameters was required.
A3: Prognostic comparability. In the case of a within-subject de-
sign, groups are comparable at baseline by definition. The partici-
pants studied should be comparable for possible confounding fac-
tors such as time since amputation, time since first walking with
the prosthesis, unilateral amputation, prosthesis experience, stump
condition (completely healed stump, residual limb stump volume,
good shaped stump free from skin problems, suture defects or hy-
pertrophic scars, no residual limb pain, swelling or pressure sores),
sound limb condition, physical condition (not suffering from any
concurrent illness, no history of lower extremity joint dysfunction
of the non-amputated leg, no concurrent painful conditions that
might affect the gait pattern, no major gait deviations, an asso-
ciated handicap that might restrict walking ability, the need to
use technical aids (walking sticks), intercurrent medical problems
liable to modify respiratory gaseous exchanges, addiction to to-
bacco, presence or absence of diabetes mellitus, peripheral or cen-
tral neurological disease affecting walking, lower-limb articular or
pre-articular damage liable to cause walking-restricting pains, no
coexisting neurologic or musculoskeletal disorders that interfere
with walking).
A4: Randomisation. In randomised controlled studies, an ade-
quate randomisation procedure should have been followed. If the
randomisation procedure was described and the procedure would
exclude bias, this criterion was scored as ’2’. In within-subject de-
signs, the internal validity does not depend on the randomisation
as in randomised controlled trials (Piantadosi 1997).
Intervention
B5: Experimental intervention. The measurements of the experi-
mental intervention should be given explicitly in such detail that
it is possible to perform a duplicate study as described.
B6: Co-interventions. This criterion tested whether co-interven-
tions were avoided or that co-interventions were comparable in
the study groups.
B7: Blinding. The outcome assessor had to be blinded to the in-
tervention. In most studies investigating prosthetic components,
it is impossible to blind the patients.
B8: Timing of the measurement. This criterion pertained to the
moment that the study was performed in relation to the time
participants were able to adapt to the intervention. An adequate
adaptation period was required.
B9: Outcome measures. The outcome variables should be ade-
quate in relation to the purpose of the study and they should have
been applied with a standardised protocol.
Statistical validity
C10: Drop-outs. The number of drop-outs and the reason for
drop-outs had to be sufficiently reported. A drop-out rate of more
than 20 per cent was considered unacceptable.
C11: Sample size. The sample size (n) in relation to the number of
independent variables (K) was adequate if the ratio n:K exceeded
10:1.
C12: Intention-to-treat. Intention-to-treat analysis should be as-
sessed in the case of drop-outs.
C13: Data presentation. This criterion required that point esti-
mates and measures of variability were presented for the primary
outcome measures.
Best-evidence synthesis
In relation to the purpose of our review, it was required that the in-
cluded studies should control for selection bias and measurement
bias. Therefore, only the studies in which the total score of the
A criteria and B criteria was six points or more (out of a possible
nine points) were used in the best-evidence synthesis. Studies were
classified as A if the total score of all criteria was 11 points or more,
and included a positive score for blinded outcome assessment (cri-
terion B7) and timing of the measurement (criterion B8). Stud-
ies were classified as B if the total score was between six and 10
points, including a positive score for timing of the measurement
(criterion B8). Studies were classified C studies if the total score of
the A criteria and B criteria was at least than six points, but with
an invalid score on the criteria B7 and B8.
In summary
A grade: 11 points or more, including six points out of the A and
B criteria, which must include B7 and B8;
B grade: between six and 10 points, including six points out of the
A and B criteria, which must include B8;
C grade: Studies with a total score of at least 6 points out of the A
and B criteria with an invalid score on the criteria B7 and B8.
Data extraction
Data were extracted from all relevant studies independently by two
reviewers (HL, CH) and entered into RevMan (RevMan 2003).
Disagreements were resolved by discussion. Where possible and
necessary, attempts were made to secure missing data from the
authors.
Data analysis
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Due to the study design of the included studies it was impossible
to attempt to pool the results of the included studies in this review,
due to:
• The study populations of all the different trials were
heterogeneous, because of the difference in the level of
amputation, the cause of amputation, and activity level of the
individuals with a lower limb amputation
• There were a lot of different interventions; in 26 trials 19
prosthetic ankle-foot mechanisms were investigated
• There were a lot of different outcome parameters, measured
in different ways.
Therefore, the data were not pooled but the results of the individ-
ual studies were reported in their groups of outcome parameters.
R E S U L T S
Description of studies
Results of the search
The searches resulted in the identification of 348 references. After
further review of the abstract and keywords, both review authors
considered 37 studies to be potentially eligible for review.
Included studies
All of the included studies were fully reported in English language
journals. Details of the methods, participants, interventions and
outcome measures of individual trials are provided in the ’Char-
acteristics of included studies’.
Design
No classical RCTs were identified but all included studies used
cross-over designs allowing sufficient control for confounding. All
the included studies used a single-arm cross-over within-subject
design, so that no randomisation of participants across different
groups took place.
Participants
The numbers of participants in the included trials ranged from 3
to 16. In most studies, participants wore prostheses that allowed
interchange of the foot component. The numbers of participants
in the included trials ranged from three to sixteen. The partici-
pants’ lower extremity was amputated for vascular, traumatic or
oncological reason. Exclusion of participants with stump prob-
lems was reported in 12 studies.
Interventions
Several different prosthetic ankle-foot mechanisms used in the in-
cluded studies: SACH-foot; Flex-foot; SAFE II; Seattle Lightfoot;
Quantum foot; Carbon Copy II; Multiflex foot; Energy-storing
Proteor foot; Single-axis foot; Greissinger
Dynamic; Re-Flex VSP; Multiple Axis; Otto Bock Multi Axial;
Otto Bock Lager; Otto Bock Dynamic Pro; Hanger Quantum;
Sten foot; C-Walk.
Outcomes
Only four studies reported subjective findings as outcome mea-
sures. Casillas 1995 developed a satisfaction index; Underwood
2004 asked their subjects to rate on a scale of 1-10; MacFarlane
1991 used the Borg-scale was used; and in Postema 1994, a ques-
tionnaire was composed to obtain the preference of the partici-
pants. Furthermore, all the studies reported one of the other out-
come measures of interest (energy expenditure, stride characteris-
tics, kinetic parameters, or kinematic parameters).
Excluded studies
Eleven studies did not meet the inclusion criteria (Alaranta 1991;
Arya 1995; Hayden 2000; James 1986; Mizuno 1992; Nyska
2002; Torburn 1994; Wagner 1987; vd Water 1998; Wirta 1991;
Yack 1999) and were excluded (see the ’Characteristics of excluded
studies’). An important reason for excluding these studies was that
the selection of the study sample was poorly described.
In addition, several identified references reported on studies
already included in the review (Culham 1984; Hsu 1999;
MacFarlane 1991; MacFarlane 1997; Postema 1994).
Risk of bias in included studies
On the whole, the methodological quality of the included studies
was moderate with the majority of the studies attaining an overall
grade of B. Of a total possible quality score of 14, the range of the
overall scores was 7 to 13, with a mean score of 9. The method-
ological quality scores are listed in Table 1 and Table 2.
In three studies it was unclear if the participants had a similar ac-
tivity level. In two studies the reason for amputation was diverse
(Boonstra 1993; Culham 1984) and in Doane 1983, the reason
for amputation was not reported. In sixteen studies, the sequence
of prosthetic ankle-foot mechanisms was randomised; of these,
only Postema 1994 described which randomisation procedure was
applied. In most studies, participants wore prostheses that allowed
interchange of the foot component, therefore these studies scored
’1’ for the B6-criterion co-interventions.However, four studies did
not report any detail of the prosthetic components of the partici-
pants, followed by a ’0’ score on this criterion (Hsu 1999; Nielsen
1988; Schmalz 2002;Underwood 2004).Only one study reported
blinding of the participants (Postema 1994). Treatment masking
or blinding is an effective way to increase the objectivity of the
person(s) observing experimental outcomes. When the treatments
are masked, the bias of the participants and observer are not likely
to influence the measurements taken.
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It is assumed that individuals with a lower limb amputation would
need a period of at least one week to acclimatise to prosthetic
feet (English 1995). This was not the case or not reported in five
studies (Goh 1984; Lehmann 1993a; Lehmann 1993b; Nielsen
1988; Schmalz 2002; Underwood 2004). If a participant did not
acclimatise to a new prosthetic foot, one could not be sure that
pertinent gait parameters would have been stabilised. Nine studies
failed to mention the number of drop-outs and in the tables or
figures it was not clear whether all the participants were able to
perform all the tests (Boonstra 1993; Cortes 1997; Doane 1983;
Goh 1984; Lehmann 1993a; Lehmann 1993b; Marinakis 2004;
Powers 1994; Schmalz 2002; Torburn 1990; Underwood 2004).
The number of participants was very low in two studies (Barth
1992; Nielsen 1988). In Barth 1992, two subgroups were inves-
tigated; each subgroup consisted of only three participants. The
population of Nielsen 1988 also consisted of only three partici-
pants. The criteria ’intention-to-treat’ was not applicable for any
of the included studies, since there were no drop-outs, or the num-
ber and reason for drop-outs was not mentioned.
Data were not presented sufficiently in five studies (Cortes 1997;
Goh 1984;Menard 1992;Nielsen 1988; Perry 1997). Cortes 1997
investigated which factors influence the individual’s gait and in
which order of importance. The results did not show the effect
of different prosthetic feet on the assessed outcome parameters in
terms of mean and standard deviation. Therefore the results of this
study cannot be included in the comparison. Perry 1997 presented
the data as a percentage of healthy non-amputated controls. How-
ever, the normative values were based on unpublished laboratory
data.
Effects of interventions
With the exception of the Borg-scale, the outcome parameters
included in this section were measured while the participants were
walking at their comfortable velocity, otherwise the datawould not
be comparable. All included trials concern transtibial amputations,
except for two studies (Boonstra 1993; MacFarlane 1997). For all
parameters in this section, the results will firstly be described for
the transtibial amputations and subsequently for the transfemoral
(MacFarlane 1997) or the transgenual amputations (Boonstra
1993), if applicable.
1. Comfortable walking velocity (meters per minute)
Seventeen studies used comfortable walking velocity as an out-
come parameter. Only two studies reported significant differences
between some prosthetic feet (Nielsen 1988; Snyder 1995). The
individuals with a traumatic transtibial amputation in Nielsen’s
study walked faster with the Flex-foot than the SACH-foot
(77.8±16.9m/min versus 71.4±15.8m/min) and individuals with
diabetic transtibial amputation in Snyder’s study reached a higher
self-selected walking velocity with the Flex-foot than the SACH-
foot (71.6±12.6m/min versus 63.6 ±10.0m/min).
2. Stride length (meters)
Ten studies used stride length as an outcome parameter. Only two
studies found significant differences between the Flex foot and
other prosthetic feet. The individuals with traumatic transtibial
amputation in Powers 1994 had a greater stride length when walk-
ing with the Flex-foot thanwith the SACHand theQuantum foot
(1.50±0.13m, vs. 1.44±0.15m and 1.44±0.15m). The individuals
with diabetic transtibial amputation in Snyder’s study also had a
greater stride lengthwhenwalkingwith the Flex-foot, compared to
the SACH, the Carbon Copy II and the Seattle foot (1.35±0.19m
vs. 1.25±0.16m, 1.27±0.17m, and 1.25±0.13m) (Snyder 1995).
3. Cadence (steps per minute)
Nine studies used cadence as an outcome parameter. None of the
studies showed differences in cadence between the several pros-
thetic feet, while walking at comfortable walking velocity.
4. Energy cost (ml oxygen per kg per minute)
Ten studies used energy cost as an outcome parameter. No signif-
icant differences were found in energy cost among the prosthetic
feet tested in the traumatic as well as the vascular group in Barth
1992. Both the vascular and traumatic group in Huang’s study
also showed no differences in energy cost when walking with the
SACH-foot, single axis, or the multiple axis (Huang 2000). For
the five individuals with transtibial amputation of Torburn’s study
there were no differences between foot-types in energy cost dur-
ing free walk (Torburn 1990). This was also the case for the nine
traumatic and the seven vascular individuals with a transtibial am-
putation in Torburn 1995.
Energy cost was identical for the two prosthetic feet as well as
for the traumatic and the vascular transtibial amputation group
of Casillas’ study when walking on level ground at self selected
walking speed (Casillas 1995). While walking on a level treadmill
at a progressive speed, the energy cost was lower with the pro-
totype foot compared to the SACH foot in the traumatic group
and the difference became more significant as speed increased
(22.11±3.29 ml oxygen/kg/min vs. 24.71±2.18 at 6 km/h). En-
ergy cost was also lower when walking with the Proteor foot com-
pared with the SACH foot with inclined and declined treadmill
walking (16.79±2.32 vs. 19.31±2.80 ml oxygen/kg/min with a
5% decline on the treadmill). When the individuals with a nonva-
scular transtibial amputation in Hsu’s study walked on the tread-
mill, energy cost was significantly decreased while walking with
the Re-Flex VSP compared with the SACH and the Flex foot at
progressive speed (36.83±5.07 ml oxygen/kg/min vs. 40.73±5.29
and 39.44±5 .37 when running at 147.51m/min), while the Flex-
foot and the SACH were not statistically significant (Hsu 1999).
For the eight individualswith a transtibial traumatic amputation in
Schmalz’ study, the values of the energy cost showed no significant
differences between the various foot designswhenwalking at 4km/
h. However, energy consumption increased when walking with
the 1S71 SACH-foot at a speed of 4.8km/h compared to the
other feet (16.1± 1.4 vs. 15.6±1.2 ml oxygen/kg/min) (Schmalz
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2002). At walking speeds of 2.5 miles per hour, the energy cost of
walking with the SACH-foot was higher than with the Flex-foot
in the three individuals with a traumatic transtibial amputation in
Nielsen 1988. However, no means and standard deviations of this
outcome parameter were presented.
For the eight individuals with a transtibial traumatic amputation
in Hsu’s study it appeared that the energy expenditure of the Flex-
foot was slightly less than that of the SACH-foot, and the dif-
ferences between the Flex-foot and the SACH-foot appeared to
progressively increase with increases in walking speed (Hsu 2006).
The C-walk appeared to have lower oxygen consumption values at
67.05 and 80.46m/min when compared with the Flex-foot. How-
ever, the differences between the foot-types in this study were not
significant.
In MacFarlane’s study, five individuals with a traumatic trans-
femoral amputation walked with a lower energy cost when walk-
ing with the Flex-foot than with the SACH-foot (16.70±0.24 vs.
17.69±0.24 ml oxygen/kg/min) (MacFarlane 1997).
5. Gait efficiency (ml oxygen per kg per meter)
Nine studies used gait efficiency as an outcome parameter. Gait
efficiency was lower with the Proteor foot compared with the
SACH-foot for the twelve individuals with a traumatic amputa-
tion in Casillas 1995 (0.22±0.04 vs. 0.24±0.04 ml oxygen/kg/
meter). Between foot-type comparisons showed progressive sepa-
ration of the energy cost values (SACH>Flex-foot>Re-Flex VSP)
with increasing walking speed. The differences appeared negligi-
ble for the lower two walking speeds. Hsu 1999 found that foot-
type comparisons for the subjects showed progressive separation
of the gait efficiency values (SACH>Flex-foot>Re-Flex VSP) with
increasing walking speed (between 53.64 m/min and 147.51 m/
min). The gait-efficiency of the Re-Flex VSP was significantly dif-
ferent compared with the SACH and the Flex-foot (0.28±0.04 vs.
0.25±0.03 ml oxygen/kg/m at a running speed of 147.51 m/min);
the differences between the SACH-foot and the Flex-foot were not
significantly different (Hsu 1999).
For each walking and running speed in Lehmann 1993a, there
were no significant differences among the three foot designs for the
nine individuals with a transtibial amputation. The same results
were found in another study of Lehmann (Lehmann 1993b), while
walking with the Seattle and the Flex-foot.
For the three individuals with a traumatic transtibial amputation
of Nielsen’s study there were no significant differences in gait ef-
ficiency between the two types of prosthetic feet at all walking
speeds (Nielsen 1988). For the eight individuals with a traumatic
transtibial amputation ofHsu’s study theC-walk and the Flex-foot
appeared to be more efficient compared with the SACH across
all tested walking speeds, and with greater differences between
the C-walk and the SACH-foot at mid-range speeds (67.05 and
80.46m/min), with greater differences between the Flex-foot and
the SACH-foot at higher walking speeds (93.87 and 107.28m/
min) (Hsu 2006). However, these results were not significant.
For the five individuals with a transtibial amputation of Torburn’s
study there were no differences between foot-types in gait effi-
ciency during free walk (Torburn 1990). This was also the case
for the nine individuals with traumatic and seven individuals with
vascular transtibial amputation in Torburn 1995.
MacFarlane 1997 found that the mean walking efficiency was
better (lower value) at each walking speed with the Flex-foot
than with the SACH-foot (0.253±0.003 ml oxygen/kg/meter vs
0.270±0.003) in five individuals with a traumatic transfemoral
amputation.
6. Borg-Scale
One study used the Borg-scale as an outcome parameter. In Mac-
Farlane’s study, walking with the SACH-foot was perceived to be
more difficult with each grade and speed condition than walk-
ing with the Flex-foot (10.4±1.6 vs. 8.6±1.1 at level walking at
medium speed) (MacFarlane 1991). The greatest difference oc-
curred on the level and incline grades.
As for patient satisfaction, the only A study (Postema 1994) con-
cluded that no specific prosthetic foot was consistently favoured
over another type of foot by individuals with a traumatic transtib-
ial amputation. Yet, in one B study, the prototype energy-stor-
ing foot (Proteor foot) scored a higher satisfaction rate than the
SACH foot in individuals with a traumatic transtibial amputation
(Casillas 1995). In one C-study the Flex foot was preferred over
the SAFE foot for perceived stability and mobility, although no
statistical analysis was performed (Underwood 2004). However,
since the prosthetic users were not blinded in MacFarlane’s, Casil-
las’ and Underwood’s studies, these results should be interpreted
with caution.
Joint motion
Ten studies used joint motion as an outcome parameter. In
Postema 1994, the range of motion (ROM) at the ankle during
the stance phase of a single-axis conventional foot was greater than
the same ROM of two energy-storing feet. This result could read-
ily be related to the mechanical characteristics of the different feet
i.e. the presence or absence of an ankle axis in the frontal plane.
Furthermore, the energy storing Flex foot showed a greater late
stance dorsiflexion compared with the conventional SACH foot
in three B studies (Powers 1994; Snyder 1995; Torburn 1990)
and two C studies (Lehmann 1993b; Schmalz 2002) on individ-
uals with traumatic and vascular transtibial amputation. The fact
that the Flex foot resulted in a greater stride-length is indicative
of a greater tibial advancement as a result of increased dorsiflexion
(Snyder 1995).
In addition, Marinakis 2004 studied the ROM of the hip, knee
and ankle joints of nine individuals with a traumatic transtibial
amputation. With the SACH-foot, the ankle joint was continu-
ously at a low-angle dorsiflexion, reaching a maximum of 3.0 de-
grees. With the Greissinger plus foot, the maximum dorsiflexion
was 6.5 degrees, and the maximum plantar flexion 11 degrees, re-
sulting in an ROM within the lower limits of the range of values
observed during measurements with the non-disabled subjects.
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D I S C U S S I O N
None of the included studies showed significant differences be-
tween any of the investigated prosthetic ankle-footmechanisms for
the comfortable walking speed or cadence. However, In individu-
als with a transtibial amputation, there seems to be a slight trend
towards a greater stride length when walking with the Flex-foot in
comparison to the SACH foot (Powers 1994; Snyder 1995).
During level treadmill walking there were no differences in energy
cost in either the individualswith a traumatic or vascular transtibial
amputations.However, whenwalking speedwas increased orwhen
subjects walked on a decline or incline treadmill, the energy cost
was lower when walking with an energy-storing foot than with
the SACH foot (Casillas 1995; Hsu 1999; Schmalz 2002). These
studies indicate that the individual with a transtibial amputation
who is active and is able to walk on inclines and declines could
benefit from an energy-storing prosthetic foot, such as the Flex-
foot, the Re-Flex foot or the Proteor foot.
In contrast, the energy cost is lower during level walking when
walking with the Flex-foot compared with the SACH-foot in indi-
viduals with a transfemoral amputation (MacFarlane 1997). This
raises the hypothesis that in high activity individuals with a trans-
femoral amputation, the design of the ankle foot mechanism may
be more important than for transtibial amputees and that more
studies are needed. High activity transfemoral users are likely to
be prescribed more sophisticated knee mechanisms and this will
impact on the decision on which foot is appropriate to comple-
ment the knee action.
When individuals with a lower limb amputation were asked which
prosthetic foot they preferred, only the A-study concluded that no
specific foot was favoured although there were differences in the
mechanical characteristics of the prosthetic feet (Postema 1994).
This implies that besides the functional benefits of a prosthesis
and the functional needs of the individual, the participants’ own
interpretationofwalkingdifficulty is also of value for the prosthetic
prescription.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is insufficient evidence from high quality comparative stud-
ies for the overall superiority of any individual type of prosthetic
ankle-foot mechanism, although there is a small trend towards the
Flex-foot in comparison with the SACH foot for greater stride
length and lower energy cost in individuals with a transtibial am-
putation, and improved gait efficiency and lower energy cost in
high activity individuals with transfemoral amputation. In pre-
scribing prosthetic-ankle foot mechanisms for individuals with a
lower limb amputation, practitioners should take into account
availability, patient functional needs, patient mobility level, type
of knee mechanism to be prescribed and the inter-relationship
with ankle-foot mechanisms, and cost.
Implications for research
For future research, functional comparisons between different
prosthetic components could be more usefully categorised accord-
ing to the level of activity and intended use in specific subgroups
of (for example) traumatic or vascular patients. Such an approach
would better acknowledge the importance of individual needs and
abilities that guide clinical decision-making in daily practice.
Functional outcomes should be assessed for various aspects of mo-
bility such as making transfers, maintaining balance, level walk-
ing, stair climbing, negotiating ramps and obstacles, and changing
walking speed. Most of the studies included in this review assessed
walking on a treadmill (at self-selected walking speeds), proba-
bly for reasons of technical and practical convenience. Indeed,
Mulder 1998 has already pointed out that the vast majority of clin-
ical studies on human walking have used rather standardised gait
assessment protocols with limited ’ecological validity’. Although
perhaps less analytic, modern systems for ambulatory monitoring
of human activity (Bussmann 2001) are able to provide objective
and valid data about (changes in) human motor behaviour dur-
ing prolonged periods of hours or days in a much more ecologi-
cally valid way. Also, subjective assessments of comfort, stability
and efficiency should certainly be used more when blinding of the
prosthetic users can be assured.
The effects of different prosthetic feet should also be evaluated in
patients with a through-knee or transfemoral amputation. Gener-
alising results from transtibial to these higher levels of amputation
may be invalid.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Barth 1992
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants Group 1: 3 men with unilateral transtibial traumatic amputation, mean age 39 years (SD 10), mean time
since amputation 22 years (SD 14).
Group 2: 3 men with unilateral transtibial vascular amputation, mean age 64 years (SD 5), mean time
since amputation 5 years (SD 3). A test prosthesis was fabricated for each subject.






5. Carbon Copy II
6. Flex-Walk
Retroreflective markers were placed at anatomical landmarks. Surface electrodes were placed at rectus
femoris, vastus lateralis, medial and lateral hamstring, bilaterally. Subjects walked at self-selected speed
using a treadmill
Outcomes 1. walking velocity
2. cadence
3. stride length
4. single-limb stance times
5. energy cost (ml oxygen/kg/meter)
6. joint motion
Notes Each foot was worn on the test prosthesis for three weeks.
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Boonstra 1993
Methods Within-subject, cross-over design
Participants 6 men and 3 women with unilateral transgenual amputation. In 4 people cause of amputation was trauma,
in 3 vascular disease, in 1 bone-cancer, and in 1 osteomyelitis, mean age 41 years (range 20-70), mean
time since amputation 9 years (range 2-25), fitted with an end bearing socket
Exclusion: painful stump with skin abrasions
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Gait analysis was performed on a 10m walkway at comfortable, fast, and slow speed and on a treadmill
(2 and 2.5 km/h and comfortable speed minus 0.5km/h)
Outcomes 1. walking speed
2. duration of swing and stance phase
3. goniometry of the hip, knee and ankles
4. range of motion of the ankle, knee, and hip
Notes At least three weeks were allowed to elapse between the changing of the foot and the evaluation
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Casillas 1995
Methods Within-subject, cross-over design
Participants Group 1: 12menwith unilateral transtibial traumatic amputation, mean age 50 years (SD 14), amputation
performed more than 2 years previously, with socket contact and a SACH-foot.
Group 2: 10 men and 2 women with unilateral transtibial vascular amputation, mean age 73 years (SD
7), amputation performed more than 4 months previously, with a socket contact and a SACH-foot.
Exclusion: an associated handicap thatmight restrict walking ability, stump problems, intercurrentmedical
problems, addiction to tobacco.
Country: USA
Interventions 1. SACH-foot
2. Energy-storing Proteor foot
Group 1: oxygen consumption was measured during rest in seated position, during walking at self-selected
velocity, walking on level treadmill at different velocities (2.4, 4 and 6km/h), and walking on treadmill
with an incline of 5% and decline of 5% at 4km/h.
Group 2: only the self-selected speed test was performed.
Outcomes 1. oxygen consumption (ml oxygen/kg/min and ml oxygen/kg/meter)
2. heart rate
3. blood pressure
For group 1 a satisfaction index was established by the subject after evaluation of each foot: the rating was
determined on a visual scale ranging from 0 to 100, 0 corresponding “entirely unsatisfactory” and 100 to
“entirely satisfactory”
Notes Subjects were requested to only use the foot to be tested in the week preceding evaluation and to not
change their routine
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Casillas 1995 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Cortes 1997
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 8 men with unilateral traumatic transtibial amputations, mean age 35 years (range 19-49), amputation
at least 2 years before the investigation, mean Day’s Activity Score 24 (range 14-39), fitted with PTB
prostheses, good shaped stump.






Participants walked at free cadence, fast, and slower (cadence from 60-140 steps per minute), on a 12m
walkway with 2 force plates, equipped with a system of polycentric electrogoniometry for themeasurement
of both limbs-hip, knee and ankle angles on the sagittal plane
Outcomes A total of 18 variables was selected:
7 were kinetic (vertical, horizontal and lateral force)
10 kinematic (ankle, knee and hip angles)
1 time-related (Single-Support Stance Time (SST))
Notes Amputees had a two-week adaptation period before a measurement
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Culham 1984
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants Group 1: 3 men with unilateral transtibial traumatic amputation, mean age 39 years (SD 10), mean time
since amputation 22 years (SD 14).
Group 2: 3 men with unilateral transtibial vascular amputation, mean age 64 years (SD 5), mean time
since amputation 5 years (SD 3). A test prosthesis was fabricated for each subject.
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Culham 1984 (Continued)





5. Carbon Copy II
6. Flex-Walk
Retroreflective markers were placed at anatomical landmarks. Surface electrodes were placed at rectus
femoris, vastus lateralis, medial and lateral hamstring, bilaterally. Subjects walked at self-selected speed
using a treadmill
Outcomes 1. walking velocity
2. cadence
3. stride length
4. single-limb stance times
5. energy cost (ml oxygen/kg/meter)
6. joint motion
Notes Each foot was worn on the test prosthesis for three weeks.
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Doane 1983
Methods Within-subject, cross-over design.
Participants 8 men with unilateral transtibial amputation, age 55-67 years, in good general health wearing a PTB
prosthesis with cuff suspension, each amputee was fitted with a temporary prosthesis.




Participants walked on a 6m walkway and were filmed simultaneously from lateral and frontal perspectives
Outcomes 1. vertical displacement and velocity of the centre of mass
2. lower limb joint angles
3. percentage of time of gait cycle of stance phase, swing phase and double support phase
Notes A time lapse of one week was allowed if the prosthetic foot was not the same design as the one worn on
their permanent prosthesis
Risk of bias
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Doane 1983 (Continued)
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Goh 1984
Methods Within-subject, cross-over design.
Participants Group 1: 6 men with transtibial unilateral amputation, mean age 53 years (SD 9), mean Day’s Activity
Score 33.
Group 2: 5 men transfemoral unilateral amputation, mean age 48 years (SD 11), mean Day’s Activity
Score 37.
Each amputee was provided with an experimental prosthesis, which was adaptable to accommodate either




Participants walked on a 20m walkway with 2 force plates and 3 cine cameras. Body markers were
positioned at anatomical landmarks
Outcomes Temporal components of stance phase: heel-strike to foot-flat, foot-flat to heel-rise, heel rise to toe-off (as
percentage of total stance phase)
Notes Participants were not able to adapt to the intervention.
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Hsu 1999
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 5 men with nonvascular unilateral transtibial amputation, mean age 32 years (range 27-36), mean time
since amputation 13.1 years (1.5-20), mean Day Activity Scale was 32 (range 12-45).





Participants walked at 5 different walking speeds (53.64, 67.05, 80.46, 93.87 and 107.28m/min) and 3
different running speeds (120.69, 134.1 and 147.51m/min)
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Hsu 1999 (Continued)
Outcomes 1. energy cost (ml oxygen/kg/min)
2. gait efficiency (ml oxygen/kg/meter)
3. Relative Exercise Intensity (expressed using the formula (exercise heart rate/age-predicted maximum
heart rate))
Notes Each subject had been walking on the prosthetic feet for at least 9 weeks per foot
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Hsu 2006
Methods Within-subject, cross-over design.
Participants 8 men with unilateral transtibial amputation, mean age 36 years (range 20-64, SD 15 years), mean





Outcomes 1. Walking speed treadmill test
2. Oxygen consumption (ml oxygen / kg/ min)
3. Heart rate
4. Gait efficiency (ml oxygen / kg / meter)
5. %APMHR
6. Physical activity (steps per day)
Notes Each subject had been walking on the prosthetic feet for at least 4 weeks per foot
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Huang 2000
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
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Huang 2000 (Continued)
Participants Group 1: 8 men with unilateral vascular transtibial amputation, mean age 62.8 years (SD 5.5) mean time
since amputation 8.9 years (SD 5.1).
Group 2: 8 men with unilateral traumatic transtibial amputation, mean age 29.8 years (SD 5.9), mean
time since amputation 7.4 years (SD 4.6).
Each participant had been wearing a variant of a PTB definitive prosthesis with a soft removable liner for
at least 1 year.





Retroflective markers were attached at anatomical landmarks. Participants walked at self-selected com-
fortable walking speed on a treadmill (0.8 - 10.0 m/h)




5. single-limb stance times
6. joint motion
Notes Each foot was worn for 3 weeks.
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Lehmann 1993a
Methods Within-subject, cross-over design.
Participants 9 unilateral transtibial amputees, age 21-53 years, at least 1 year post-amputation, independent functional
ambulators able to achieve walking speeds up to 120m/min and running speeds up to 200m/min.






Biomechanical comparison was performed on both prosthetic and sound sides, during walking (73,90,
107, and 120m/min) and running (140,160,180, and 200m/min) on a treadmill
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Lehmann 1993a (Continued)
Outcomes 1. metabolic efficiency (ml oxygen/kg/meter)
2. comfortable self-selected walking speed
3. biomechanical parameters relating to gait events, ground reaction forces, joint angles, and moment
Notes Participants were not able to adapt to the intervention.
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Lehmann 1993b
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 10 unilateral transtibial amputees, age 21-36 years, at least 1 year post-amputation, independent functional
ambulators able to achieve a walking speed up to 120m/min and running speeds up to 200m/min, each
amputee was fitted with a PTB socket




2. Seattle Lite foot
Reflective markers were placed on anatomical landmarks. A force platform was situated on the walkway.
For the measurements of metabolic rate and efficiency, a range of walking speeds was selected (73,90,107,
and 120m/min) on the treadmill
Outcomes 1. metabolic rate (cal/kg/min)
2. metabolic efficiency (cal/kg/meter)
3. self-selected walking speed
4. measurements of lower extremity kinematics, gait events, ground reaction forces
Notes Participants were not able to adapt to the intervention.
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
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MacFarlane 1991
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 7 men with unilateral traumatic transtibial amputation, mean age 35 years (range 19-49), mean time





A 15m walkway was used to determine the self-selected walking speed. Gait measurements took place
while participants walked on a treadmill. Each session consisted of a level, decline (-8.5%) and then an
incline (+8.5%) walking test. Each test consisted of 3 minute bouts at slow (53.6m/min), medium (67m/
min), and fast (80.5m/min) speeds. Under each grade and speed condition, participants were filmed for
three gait cycles
Outcomes 1. self-selected walking speed
2. step-length
3. duration of early stance, late stance, early swing, late swing, double support, single support
4. symmetry ratios for step length
5. vertical trunk displacement
6. Borg-scale; an increasing scale from 0 to 20, where 0 equals very, very easy and 20 equals very, very
difficult
Notes Each participant had been walking on the prosthetic feet for at least 6 months per foot
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
MacFarlane 1997
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 5 active men with unilateral traumatic transfemoral amputation, mean age 37 years (SD 5.1), mean time
since amputation 10 years (SD 3.5), participants could walk continuously for at least 5 minutes across a




Participants walked continually around a 50 meter walkway at five walking speeds (40.2, 56.6, 67.1, 80.
5, 93.9m/min). A video camera recorded four strides of each participant’s walking
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MacFarlane 1997 (Continued)
Outcomes 1. relative exercise intensity (percent of age-predicted maximum heart rate)
2. energy cost (ml oxygen/kg/min)
3. gait efficiency (ml oxygen/kg/meter)
4. swing-, stance-, double-, and single-support phase variables
5. step length
6. symmetry ratios
Notes Participants wore the testing prosthesis continuously for the week prior to testing
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Marinakis 2004
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 9 male participants with a unilateral (right) transtibial traumatic amputation. Mean age 54.3 years (SD
2.1), mean time from amputation 38.9 weeks (SD 3.1), mean time from limb fitting was 16.3 weeks (SD
5.8).
Country: United Kingdom
Interventions 1. SACH foot
2. Greissinger Plus Foot
Outcomes 1. Range of motion of hip, knee and ankle
2. walking speed
3. cadence
4. stance phase period
5. symmetry indexes of temporal gait parameters
Notes Participants were able to adapt to the new prosthetic foot for 1 week
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
21Prescription of prosthetic ankle-foot mechanisms after lower limb amputation (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Menard 1992
Methods Within-subject, cross-over design.
Participants 8 physically active men with unilateral traumatic transtibial amputation, mean age 37 years (range 31-




Participants walked on a 20m indoor runway with a force platform, they walked at their natural cadence
Outcomes Ground reaction forces (in units of newtons per kilogram body mass (N/kg))
Notes The participants had used the two prostheses for equal amounts of time for at least two weeks before
testing
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Nielsen 1988
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 7 men with unilateral traumatic transtibial amputation, mean age 27 years (SD 7). All were proficient




A 15m walkway was used for measuring the self-selected walking speed.
The actual walking tests were performed on a treadmill, walking at each of seven velocities (1, 1.5, 2, 2.
5, 3, 3.5, 4, 4.5 m/h)
Outcomes 1. heart rate
2. %MHR (percent of age-predicted maximum heart rate)
3. oxygen uptake
4. gait efficiency (ml oxygen/kg/meter)
5. self-selected walking speed
Notes Participants were not able to adapt to the intervention.
Risk of bias
Bias Authors’ judgement Support for judgement
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Nielsen 1988 (Continued)
Allocation concealment? Unclear risk D - Not used
Perry 1997
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 10 men with vascular transtibial amputation, mean age 62.4 years (range 49-72), with completely healed
amputation and residual stump volume stability. All participants were fitted with a prosthesis that allowed
interchange of the foot components.
Country: USA
Interventions 1. Single Axis
2. Seattle Lite
3. Flex-foot
Gait analyses were done at a self-selected velocity over a level 10mwalkway with a force plate. Foot switches
were taped to the soles of the shoes to calculate stride characteristics and foot-floor contact patterns.
Reflective markers were placed at anatomical landmarks
Outcomes 1. gait velocity
2. cadence
3. stride length
4. foot floor contact patterns
5. joint motion in the sagittal plane
Notes Each foot was worn for approximately 1 month prior to testing
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? High risk C - Inadequate
Postema 1994
Methods Quasi randomised controlled trial.
Double-blind randomised trial, within-subject, cross-over design
Participants 9 men and 1 woman with transtibial amputation. Mean age 49 years (range 34-66), mean time since




Interventions 1. Otto Bock Multi Axial (conventional foot)
2. Otto Bock Lager (conventional foot)
3. Otto Bock Dynamic Pro (energy-storing foot)
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Postema 1994 (Continued)
4. Hanger Quantum (energy-storing foot).
Outcomes 1. walking velocity
2. cadence
3. range of motion of the hips, the knees and the ankles during early stance plantar flexion and late stance
dorsiflexion
4. a questionnairewas composed to obtain information about the preference of the participants. It consisted
of 27 questions that were grouped into 4 categories: stability while standing, stability while walking,
functional factors and special activities. The questions were answered in the form of a score in an increasing
scale from 0 to 10, the mean score of all questions was the general score for a foot
Notes Every time a foot was supplied, there was a habituation period of 2 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Low risk A - Adequate
Powers 1994
Methods Quasi randomised controlled trial.
Within-subject, cross-over design.
Participants 10 men with transtibial traumatic amputations, mean age 50 years (range 22-72), mean time since
amputation 18 years (range 3-48), independent community ambulators, displayed volume stability of the








Foot switches were taped to the soles of the shoes to calculate stride characteristics and foot-floor contact
patterns. Reflective markers were placed at anatomical landmarks.
Participants walked at a self-selected speed along a 10m walkway with force plate and motion data being
collected simultaneously
Outcomes 1. walking velocity
2. cadence
3. stride length
4. ground reaction forces for the prosthetic and the sound limb
5. ankle motion (degrees)
Notes Each participant was given an accommodation period of 1 month
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Powers 1994 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Rao 1998
Methods Within-subject, cross-over design.
Participants 9 men with unilateral transtibial vascular amputation, mean age 62 years (SD 7), with well healed ampu-





Foot switches were used to measure stride characteristics. Retroreflective markers at anatomic landmarks
were used for motion data. Gait testing was performed over a level 10m walkway




Notes Each participant accommodated to a particular foot for approximately one month
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Schmalz 2002
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 8 participants with transtibial traumatic amputation, mean age 44 years (range 17-70), mean time since
amputation 18 years (3-53)
Exclusion: cardiovascular disorders
Country: Germany
Interventions 1. Otto Bock 1S71
2. Otto Bock 1D10
3. Otto Bock 1D25
4. Otto Bock 1C40
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Schmalz 2002 (Continued)
5. Flex Walk II
Gait testing was performed during level walking and on the treadmill. Participants walked at 4km/h and
4.8km/h on the treadmill
Outcomes 1. Oxygen consumption
2. Walking speed
3. Stride length
Notes Participants were not able to adapt to the intervention.
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Snyder 1995
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 7 men with diabetic transtibial amputation resulting from vascular insuffiencey, mean age 62 years (range
45-70), all were community ambulators and demonstrated residual limb volume stability of at least 6
months.
Exclusion: assistive devices, complications associated with residual limb breakdown or resting limb pain.
Country: USA
Interventions 1. Flex-foot
2. Carbon Copy II
3. Seattle Elite foot
4. Quantum
5. SACH
Foot switcheswere used to calculate stride characteristics and foot-floor contact patterns. Reflectivemarkers
were placed at specific anatomic positions. Participants walked during a self-selected free walking speed
while walking along a 10m walkway with force plate
Outcomes 1. walking velocity
2. stride length
3. cadence
4. ankle, knee and hip motion
5. vertical ground reaction forces
Notes Participants were given an accommodation period of 1 month.
Risk of bias
Bias Authors’ judgement Support for judgement
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Snyder 1995 (Continued)
Allocation concealment? Unclear risk D - Not used
Torburn 1990
Methods Quasi-randomised controlled trial. Within-subject, cross-over design
Participants 5 men with transtibial amputation (3 traumatic and 2 dysvascular), mean age 48 years (range 43-58)
, mean time since amputation 11.3 years (range 2.5-20), all were independent community ambulators,
each subject displayed volume stability of the residual limb for at least 30 months, each subject was fitted








Gait analysis was done during self-selected free and fast-paced walking over a 10m level walkway with
a force plate. Foot switches were used to calculate stride characteristics and foot-floor contact pattern.
Reflective markers were placed at anatomical landmarks
Outcomes 1. walking velocity
2. cadence
3. stride length
4. electromyographic activity of the vastus lateralis, long head of the biceps femoris, and the gluteus
maximus
5. sagittal plane motion of the pelvis, thigh, knee, and ankle
6. energy cost (ml oxygen/kg/min and ml oxygen/kg/meter)
Notes Each participant was given an accomodation period of approximately one month
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Torburn 1995
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants Group 1: 9 men with unilateral transtibial traumatic amputations, mean age 51 years (SD 16).
Group 2: 7 men with unilateral transtibial vascular amputations, mean age 62 years (SD 8).
Participants were independent community ambulators
Exclusion: assistive device and history of compliance
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A level 60.5m outdoor track was used for the walking trials.
Outcomes 1. respiration rate
2. heart rate
3. stride frequency
4. self-selected free walking speed
5. energy expenditure (ml oxygen/kg/meter)
Notes Participants were given a accommodation period of 1 month to adjust to each prosthetic foot
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? Unclear risk D - Not used
Underwood 2004
Methods Quasi-randomised controlled trial.
Within-subject, cross-over design.
Participants 11 individuals with a unilateral traumatic transtibial amputation (8 males, 3 females), mean age 42.5 y
(SD 13.1, range 22-59), mean time since amputation 11.1 y (SD 13.3, range 1-31), participants were able
to ambulate independently, did not require assistive devices for ambulation ,did not experience stump
pain or tenderness or other cardiovascular, neurological or musculoskeletal conditions
Interventions 1. SAFE II
2. Flex-Walk





6. peak moments of ankle, knee and hip
7. peak powers of ankle, knee and hip in sagittal and frontal plane
8. questionnaire on stability and mobility of the prosthetic foot (on a scale of 1-10)
Notes Subjects could become familiar and comfortable with the properties of each prosthetic foot for a minimum
of 30 minutes
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Underwood 2004 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment? High risk C - Inadequate
Cadence: steps per minute
kg: kilograms
km/h: kilometres per hour
m: metres
m/h: miles per hour
m/min: metres per minute
N/kg: Newton per kilograms
PTB: Patellar Tendon Bearing
SD: standard deviation
transgenual amputation: through-knee amputation
y: years
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alaranta 1991 No description of the study population, no randomisation, no time to adapt to the new prosthetic foot
Arya 1995 A heterogeneous study population, no randomisation, no time to adapt to the new prosthetic foot, inadequate data
presentation
Hayden 2000 A heterogeneous study population, no time to adapt to the new prosthetic foot
James 1986 A heterogeneous study population, no randomisation, no time to adapt to the new prosthetic foot, inadequate data
presentation
Mizuno 1992 Unclear study-design. Information about study population is unclear
Nyska 2002 No description of the study population, a heterogeneous study population, no randomisation, inadequate descrip-
tion of the experimental intervention, no time to adapt to the new prosthetic foot, too small sample size, inadequate
data presentation
Torburn 1994 No description of the study population, no randomisation
vd Water 1998 No description of the study population, no randomisation, inadequate description of the experimental intervention,
comparison between The Camp Normal Activity Foot and the subject’s own prosthesis
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(Continued)
Wagner 1987 No description of the study population, no randomisation, inadequate description of the experimental intervention,
no time to adapt to the new prosthetic foot
Wirta 1991 A heterogeneous study population, no randomisation, no time to adapt to the new prosthetic foot, inadequate data
presentation
Yack 1999 No description of the study population, inadequate description of the experimental intervention, no time to adapt
to the new prosthetic foot, too small sample size
A D D I T I O N A L T A B L E S
Table 1. Methodological quality assessment: A and B criteria
Study id A1 A2 A3 A4 B5 B6 B7 B8 B9
Barth
1992
1 1 1 1 1 1 0 1 1
Boonstra
1993
1 0 1 0 1 1 0 1 1
Casillas
1995
1 1 1 0 1 1 0 1 1
Cortes
1997
1 1 1 1 1 1 0 1 1
Culham
1984
1 0 1 1 1 1 0 1 1
Doane
1983
1 0 1 0 1 1 0 1 1
Goh 1984 1 1 1 0 1 1 0 0 1
Hsu 1999 1 1 1 1 1 0 0 1 1
Hsu 2006 1 1 1 0 1 1 0 1 1
Huang
2000
1 1 1 1 1 1 0 1 1
Lehmann
1993a
1 1 1 0 1 1 0 0 1
Lehmann
1993b
1 1 1 1 1 1 0 0 1
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Table 1. Methodological quality assessment: A and B criteria (Continued)
MacFar-
lane 1991
1 1 1 1 1 1 0 1 1
MacFar-
lane 1997
1 1 1 1 1 1 0 1 1
Marinakis
2004
1 1 1 0 1 1 0 1 1
Menard
1992
1 1 1 0 1 1 0 1 1
Nielsen
1988
1 1 1 1 1 0 0 0 1
Perry 1997 1 1 1 1 1 1 0 1 1
Postema
1994
1 1 1 2 1 1 1 1 1
Powers
1994
1 1 1 1 1 1 0 1 1
Rao 1998 1 1 1 0 1 1 0 1 1
Schmalz
2002
1 1 1 1 1 0 0 0 1
Snyder
1995
1 1 1 1 1 1 0 1 1
Torburn
1990
1 0 1 1 1 1 0 1 1
Torburn
1995




1 1 1 1 1 0 0 0 1
Table 2. Methodological quality assessment: C criteria and total scores
Study id C10 C11 C12 C13 Total: A+B criteria Total: C criteria Total:A+B+C crite-
ria
Overall Grade
Barth 1992 1 0 na 1 8 2 10 B
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Table 2. Methodological quality assessment: C criteria and total scores (Continued)
Boonstra
1993
0 1 na 1 6 2 8 B
Casillas
1995
1 1 na 1 7 4 11 B
Cortes 1997 0 1 na 0 8 1 9 B
Culham
1984
1 1 na 1 7 3 10 B
Doane 1983 0 1 na 1 6 2 8 B
Goh 1984 0 1 na 0 6 1 7 C
Hayden
2000
0 1 na 1 6 2 8 C
Hsu 1999 1 1 na 1 7 3 10 B
Hsu 2006 1 0 1 1 7 3 10 B
Huang 2000 1 1 na 1 8 3 11 B
Lehmann
1993a
0 1 na 1 6 2 8 C
Lehmann
1993b
0 1 na 1 7 2 9 C
MacFarlane
1991
1 1 na 1 8 3 11 B
MacFarlane
1997
1 1 na 1 8 3 11 B
Marinakis
2004
0 0 na 1 7 1 8 B
Menard
1992
1 1 na 0 7 2 9 B
Nielsen
1988
1 0 na 0 6 1 7 C
Perry 1997 1 1 na 0 8 2 10 B
Postema
1994
1 1 na 1 10 3 13 A
32Prescription of prosthetic ankle-foot mechanisms after lower limb amputation (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 2. Methodological quality assessment: C criteria and total scores (Continued)
Powers 1994 0 1 na 1 8 2 10 B
Rao 1998 1 1 na 1 7 3 10 B
Schmalz
2002
0 1 na 1 6 2 8 C
Snyder 1995 1 1 na 1 8 3 11 B
Torburn
1990
0 1 na 1 7 2 9 B
Torburn
1995
1 1 na 1 8 3 11 B
Underwood
2004
0 1 na 1 6 2 8 C
A P P E N D I C E S





4. (knee adj3 (disarticulat$ or exarticulat$)).tw.
5. (amputat$ adj3 (transfemoral or transtibial or lower limb or












#01 amputee* in ti,ab
#02 AMPUTEES/ all subheadings
#03 #1 or #2
#04 (knee near (disarticulat* or exarticulat*)) in ti,ab
#05 (amputat* near (transfemoral or transtibial or lower-limb or
lower-extremity or above-knee or below-knee or through-knee))
in ti,ab
#06 DISARTICULATION/ all subheadings
#07 AMPUTATION/ all subheadings
#08 AMPUTATION, TRAUMATIC/ all subheadings
#09 AMPUTATION STUMP/ all subheadings
#10 #6 or #7 or #8 or #9
#11 (transfemoral or transtibial or lower-limb or lower-extremity
or knee) in ti,ab
#12 explode LEG/ all subheadings
#13 #11 or #12
#14 #10 and #13
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(Continued)
15. or/3-5,14
16. ((SACH adj5 feet) or (Sach adj5 foot) or (Flex adj5 feet) or
(Flex adj5 foot) or (Seattle adj5 feet) or (Seattle adj5 foot) or
(Single-Axis adj5 feet) or (Single-Axis adj5 foot) or (Golden-Ankle
adj5 feet) or (Golden-ankle adj5 foot)).tw.
17. ((foot or feet) adj3 (energy-storing or ankle-mechanism or
conventional)).tw.
18. ((prosthetic or prosthes?s) adj3 (foot or feet or ankle$ or lower-
extremity)).tw.
19. Artificial limbs/
20. (artificial adj3 (leg or foot or feet or limb)).tw.
21. ((prosthetic$ or prosthes?s) adj3 (prescription$ or outcome$
or profile or assessment or casting)).tw.
22. or/16-21
23. (subjective-findings or preference? or satisfaction or comfort
or Borg-scale? or rating-scale? or ease).tw.
24. (oxygen-uptake or physiological-measurement or metabolic-
cost or oxygen-cost or energy-cost or energy-demands or energy-
expenditure or energy-consumption or heart-rate or pulse).tw.
25. (gait-pattern or gait-characteristics or walking-speed or walk-
ing-velocity or comfortable-speed or walking-distance or cadence
or stride-characteristics or stride-length or step-length or stride-
time or stance-phase or swing-phase).tw.
26. (kinetic-parameters or ground-reaction-force?).tw.
27. (joint-motion or ankle-dorsiflexion or ankle-plantarflexion or





31. randomized controlled trial.pt.
32. controlled clinical trial.pt.
33. Random Allocation/
34. Double Blind Method/
35. Single Blind Method/
36. exp Cross-Over Studies/
37. or/31-36
38. ((clinical or controlled or comparative or placebo or prospec-
tive$ or randomi#ed) adj3 (trial or study)).tw.
39. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$
or order$)).tw.
40. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)
).tw.
41. (cross?over$ or (cross adj1 over$)).tw.
42. ((allocat$ or allot$ or assign$ or divid$) adj3 (condition$ or




#15 #3 or #4 or #5 or #14
#16 ((SACH near feet) or (SACH near foot) or (Flex near feet)
or (Flex near foot) or (Seattle near feet) or (Seattle near foot) or
(Single-Axis near feet) or (Single-Axis near foot) or (Golden-Ankle
near feet) or (Golden-ankle near foot)) in ti,ab
#17 ((foot or feet) near (energy-storing or ankle-mechanism or
conventional)) in ti,ab
#18 ((prosthetic? or prosthes?s) near (foot or feet or ankle* or
lower-extremity)) in ti,ab
#19 ARTIFICIAL LIMBS/ all subheadings
#20 (artificial near (leg or foot or limb)) in ti,ab
#21 ((prosthetic? or prosthes?s) near (prescription? or outcome?
or profile? or assessment? or casting)) in ti,ab 1351
#22 #16 or #17 or 18 or #19 or #20 or #21
#23 (subjective-findings or preference? or satisfaction or comfort
or Borg-scale? or rating-scale? or ease or questionnaire? or Pros-
thesis-Evaluation-Questionnaire or Prosthetic-Profile-of-the-Am-
putee or Locomotor-Capabilities-Index or Sickness-Impact-Pro-
file or Nottingham-Health-Profile or Reintegration-to-Normal-
Living) in ti,ab
#24 (oxygen-uptake or physiological-measurement or metabolic-
cost or oxygen-cost or energy-cost or energy-demands or energy-
expenditure or energy-consumption or heart-rate or pulse) in ti,
ab
#25 (gait-pattern or gait-characteristics or walking-speed or walk-
ing-velocity or comfortable-speed or walking-distance or cadence
or stride-characteristics or stride-length or step-length or stride-
time or stance-phase or swing-phase) in ti,ab
#26 (kinetic-parameters or ground-reaction-force?) in ti,ab 3
#27 (joint-motion or ankle-dorsiflexion or ankle-plantarflexion
or knee-flexion or knee-extension or hip-flexion or hipextensions
or power-output or tibial advancement) in ti,ab
#28 #23 or #24 or #25 or #26 or #27
#29 #22 or #28
#30 #15 and #29
#31 RANDOMIZED-CONTROLLED-TRIAL in PT




#36 explode CROSS-OVER-STUDIES/ all subheadings
#37 #31 or #32 or #33 or #34 or #35 or #36
#38 ((clinical or controlled or comparative or placebo or prospec-
tive* or random*) near (trial or study)) in ti,ab
#39 (random* near (allocat* or allot* or assign* or basis* or divid*
or order*)) in ti,ab
#40 ((singl* or double* or trebl* or tripl*) near (blind* or mask*)
) in ti,ab
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45. and/30,44 #41 (crossover or (cross-over*)) in ti,ab
#42 ((allocat* or allot* or assign* or divid*) near (condition* or
experiment* or intervention* or treatment* or therap* or control*
or group*)) in ti,ab
#43 #38 or #39 or #40 or #41 or #42
#44 #37 or #43
#45 #30 and #44
Appendix 2. EMBASE search strategy
OVID Web
1. amputee$.tw.
2. (knee adj3 (disarticulat$ or exarticulat$)).tw.










13. exp Leg Amputation/
14. Foot Amputation/
15. or/1-3,12-14
16. ((SACH adj5 feet) or (SACH adj5 foot) or (Flex adj5 feet) or (Flex adj5 foot) or (Seattle adj5 feet) or (Seattle adj5 foot) or (Single-
Axis adj5 feet) or (Single-Axis adj5 foot) or (Golden-Ankle adj5 feet) or (Golden-ankle adj5 foot)).tw.
17. ((foot or feet) adj3 (energy-storing or ankle-mechanism or conventional)).tw.
18. ((prosthetic or prosthes?s) adj3 (foot or feet or ankle$ or lower-extremity)).tw.
19. Limb Prosthesis/
20. (artificial adj3 (leg or foot or feet or limb)).tw.
21. ((prosthetic$ or prosthes?s) adj3 (prescription$ or outcome$ or profile or assessment or casting)).tw.
22. or/16-21
23. (subjective-findings or preference? or satisfaction or comfort or Borg-scale? or rating-scale? or ease).tw.
24. (oxygen-uptake or physiological-measurement or metabolic-cost or oxygen-cost or energy-cost or energy-demands or energy-
expenditure or energy-consumption or heart-rate or pulse).tw.
25. (gait-pattern or gait-characteristics or walking-speed or walking-velocity or comfortable-speed or walking-distance or cadence or
stride-characteristics or stride-length or step-length or stride-time or stance-phase or swing-phase).tw.
26. (kinetic-parameters or ground-reaction-force?).tw.
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31. exp Randomized Controlled trial/
32. exp Double Blind Procedure/
33. exp Single Blind Procedure/
34. exp Crossover Procedure/
35. Controlled Study/
36. or/31-35
37. ((clinical or controlled or comparative or placebo or prospective$ or randomi#ed) adj3 (trial or study)).tw.
38. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).tw.
39. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).tw.
40. (cross?over$ or (cross adj1 over$)).tw.




44. limit 43 to human
45. and/30,44
Appendix 3. Cochrane search strategy
Wiley InterScience
#1 amputee* in Title, Abstract or Keywords in all products
#2 MeSH descriptor Amputees explode all trees in MeSH products
#3 (knee near (disarticulat* or exarticulat*)) in Title, Abstract or Keywords in all products
#4 (amputat* near (transfemoral or transtibial or lower limb or lower extremity or above knee or below knee or through knee)) in
Title, Abstract or Keywords in all products
#5 MeSH descriptor Disarticulation explode all trees in MeSH products
#6 MeSH descriptor Amputation, Traumatic explode all trees in MeSH products #7 MeSH descriptor Amputation, this term only
in MeSH products
#8 MeSH descriptor Amputation Stumps explode all trees in MeSH products
#9 (#5 OR #6 OR #7 OR #8)
#10 (transfemoral or transtibial or lower limb or lower extremity or knee) in Title, Abstract or Keywords in all products
#11 MeSH descriptor Leg explode all trees in MeSH products
#12 (#10 OR #11)
#13 (#9 AND #12)
#14 (#1 OR #2 OR #3 OR #4 OR #13)
#15 ((SACHnear feet) or (SACH near foot) or (Flex near feet) or (Flex near foot) or (Seattle near feet) or (Seattle near foot) or (Single-
Axis near feet) or (Single-Axis near foot) or (Golden-Ankle near feet) or (Golden-ankle near foot)) in Title, Abstract or Keywords in
all products
#16 (foot near (energy-storing or ankle-mechanism or conventional)) in Title, Abstract or Keywords or (feet near (energy-storing or
ankle-mechanism or conventional)) in Title, Abstract or Keywords in all products
#17 (prosthetic near (foot or feet or ankle* or lower-extremity)) in Title, Abstract or Keywords or (prosthes* near (foot or feet or
ankle* or lower-extremity)) in Title, Abstract or Keywords in all products
#18 MeSH descriptor Artificial Limbs, this term only in MeSH products
#19 (artificial near (leg or foot or feet or limb)) in Title, Abstract or Keywords in all products
#20 (prosthetic* near (prescription* or outcome* or profile or assessment or casting)) in Title, Abstract or Keywords or (prosthes*
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near (prescription* or outcome* or profile or assessment or casting)) in Title, Abstract or Keywords in all products
#21 (#15 OR #16 OR #17 OR #18 OR #19 OR #20)
#22 (subjective-findings or (subjective findings) or preference* or satisfaction or comfort or Borg-scale* or (Borg scale*) or rating-
scale* or (rating scale*) or ease) in Title, Abstract or Keywords in all products
#23 (oxygen-uptake or (oxygen uptake) or physiological-measurement or (physiological measurement) ormetabolic-cost or (metabolic
cost) or oxygen-cost or (oxygen cost) or energy-cost or (energy cost ) or energy-demands or (energy demands) or energy-expenditure
or (energy expenditure) or energy-consumption or heart-rate or (heart rate) or pulse) in Title, Abstract or Keywords in all products
#24 (gait-pattern or (gait pattern) or gait-characteristics or (gait characteristics) or walking-speed or (walking speed) or walking-
velocity or (walking velocity) or comfortable-speed or (comfortable speed) or walking-distance or (walking distance) or cadence or
stride-characteristics or (stride characteristics) or stride-length or (stride length) or step-length or (step length) or stride-time or (stride
time) or stance-phase or (stance phase) or swing-phase or (swing phase)) in Title, Abstract or Keywords in all products
#25 (kinetic-parameters or (kinetic parameters) or ground-reaction-force* or (ground reaction force*)) in Title, Abstract or Keywords
in all products
#26 (joint-motion or ankle-dorsiflexion or ankle-plantarflexion or knee-flexion or knee-extension or hip-flexion or hip-extensions or
power-output or tibial-advancement or joint motion or ankle dorsiflexion or ankle plantarflexion or knee flexion or knee extension
or hip flexion or hip extensions or power output or tibial advancement) in Title, Abstract or Keywords in all products
#27 (#22 OR #23 OR #24 OR #25 OR #26)
#28 (#21 OR #27)
#29 (#14 AND #28)





4. (knee adj3 (disarticulat$ or exarticulat$)).tw.
5. (amputat$ adj3 (transfemoral or transtibial or lower limb or lower extremity or above knee or below knee or through knee)).tw.











17. ((SACH adj5 feet) or (Sach adj5 foot) or (Flex adj5 feet) or (Flex adj5 foot) or (Seattle adj5 feet) or (Seattle adj5 foot) or (Single-
Axis adj5 feet) or (Single-Axis adj5 foot) or (Golden-Ankle adj5 feet) or (Golden-ankle adj5 foot)).tw.
18. ((foot or feet) adj3 (energy-storing or ankle-mechanism or conventional)).tw.
19. ((prosthetic or prosthes?s) adj3 (foot or feet or ankle$ or lower-extremity)).tw.
20. Limb Prosthesis/
21. (artificial adj3 (leg or foot or feet or limb)).tw.
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22. ((prosthetic$ or prosthes?s) adj3 (prescription$ or outcome$ or profile or assessment or casting)).tw.
23. or/17-22
24. (subjective-findings or preference? or satisfaction or comfort or Borg-scale? or rating-scale? or ease).tw.
25. (oxygen-uptake or physiological-measurement or metabolic-cost or oxygen-cost or energy-cost or energy-demands or energy-
expenditure or energy-consumption or heart-rate or pulse).tw.
26. (gait-pattern or gait-characteristics or walking-speed or walking-velocity or comfortable-speed or walking-distance or cadence or
stride-characteristics or stride-length or step-length or stride-time or stance-phase or swing-phase).tw.
27. (kinetic-parameters or ground-reaction-force?).tw.





32. exp Clinical Trials/
33. exp Evaluation Research/
34. exp Comparative Studies/
35. exp Crossover Design/
36. clinical trial.pt.
37. or/32-36
38. ((clinical or controlled or comparative or placebo or prospective or randomi#ed) adj3 (trial or study)).tw.
39. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).tw.
40. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).tw.
41. (cross?over$ or (cross adj1 over$)).tw.





Appendix 5. AMED search strategy
OVID Web
1. amputee$.tw.
2. (knee adj3 (disarticulat$ or exarticulat$)).tw.









12. ((SACH adj5 feet) or (Sach adj5 foot) or (Flex adj5 feet) or (Flex adj5 foot) or (Seattle adj5 feet) or (Seattle adj5 foot) or (Single-
Axis adj5 feet) or (Single-Axis adj5 foot) or (Golden-Ankle adj5 feet) or (Golden-ankle adj5 foot)).tw.
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13. ((foot or feet) adj3 (energy-storing or ankle-mechanism or conventional)).tw.
14. ((prosthetic or prosthes?s) adj3 (foot or feet or ankle$ or lower-extremity)).tw.
15. Artificial limbs/ or Prosthesis Design/
16. (artificial adj3 (leg or foot or feet or limb)).tw.
17. ((prosthetic$ or prosthes?s) adj3 (prescription$ or outcome$ or profile or assessment or casting)).tw.
18. or/12-17
19. (subjective-findings or preference? or satisfaction or comfort or Borg-scale? or rating-scale? or ease).tw.
20. (oxygen-uptake or physiological-measurement or metabolic-cost or oxygen-cost or energy-cost or energy-demands or energy-
expenditure or energy-consumption or heart-rate or pulse).tw.
21. (gait-pattern or gait-characteristics or walking-speed or walking-velocity or comfortable-speed or walking-distance or cadence or
stride-characteristics or stride-length or step-length or stride-time or stance-phase or swing-phase).tw.
22. (kinetic-parameters or ground-reaction-force?).tw.





27. randomized controlled trial.pt.
28. controlled clinical trial.pt.
29. Random Allocation/
30. Double Blind Method/
31. ((clinical or controlled or comparative or placebo or prospective$ or randomi#ed) adj3 (trial or study)).tw.
32. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).tw.
33. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).tw.
34. (cross?over$ or (cross adj1 over$)).tw.
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